Press Release|

SHL Medical’s COVID-19 statement

Virus 1760x420

In response to the global effect of the Coronavirus (COVID-19), SHL Medical has taken proactive measures to protect the health and safety of our colleagues and ensure the continuity of business operations for our customers. As a world-leading provider of autoinjectors for major pharmaceutical companies worldwide, we are also committed to ensuring supply for the end-users of our customer’s drug delivery products.

SHL officially deployed precautionary measures in January and has since been closely monitoring the situation on a continuous basis. Our measures encompass both our business operations and employee health.

Click here to read our full response statement.

About SHL

SHL Group is a world-leading solutions provider in the design, development, and manufacturing of advanced drug delivery devices such as autoinjectors, pen injectors and advanced inhaler systems. We also offer core competencies and services in the fields of medtech and patient care solutions. With locations in Taiwan, Switzerland, Sweden, China and the US, our experienced engineers and designers develop product enhancements as well as breakthrough drug delivery and patient care solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high volume and high viscosities and can be enhanced through digital implementations.

With over 4,800 employees worldwide, SHL Group consists of several distinct group companies:

SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe.

SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use.

SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products.

For additional information, visit

Media contact:


Related News